Storage solutions: treating lysosomal disorders of the brain
Top Cited Papers
- 27 July 2005
- journal article
- review article
- Published by Springer Nature in Nature Reviews Neuroscience
- Vol. 6 (9) , 713-725
- https://doi.org/10.1038/nrn1725
Abstract
Many neurodegenerative diseases are characterized by the accumulation of undegradable molecules in cells or at extracellular sites in the brain. One such family of diseases is the lysosomal storage disorders, which result from defects in various aspects of lysosomal function. Until recently, there was little prospect of treating storage diseases involving the CNS. However, recent progress has been made in understanding these conditions and in translating the findings into experimental therapies. We review the developments in this field and discuss the similarities in pathological features between these diseases and some more common neurodegenerative disorders.Keywords
This publication has 145 references indexed in Scilit:
- A Proteomic Analysis of Lysosomal Integral Membrane Proteins Reveals the Diverse Composition of the OrganelleMolecular & Cellular Proteomics, 2005
- Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseasesNature Cell Biology, 2004
- Sphingolipidoses in TurkeyBrain & Development, 2004
- Deranged neuronal calcium signaling and Huntington diseasePublished by Elsevier ,2004
- Taking stock and planning for the next decade: Realistic prospects for stem cell therapies for the nervous systemJournal of Neuroscience Research, 2004
- Endocytic recyclingNature Reviews Molecular Cell Biology, 2004
- Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendationsPublished by Elsevier ,2004
- Calcium signalling: dynamics, homeostasis and remodellingNature Reviews Molecular Cell Biology, 2003
- Inflammatory processes in amyotrophic lateral sclerosisMuscle & Nerve, 2002
- The endocytic pathway: a mosaic of domainsNature Reviews Molecular Cell Biology, 2001